The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes


SARICI A. , AR M. C. , Yokus O., ONGOREN S., Ayer M., Altindal S., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.59, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Purpose: Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to investigate both the impact of comorbidities and transfusion frequencies on the survival and quality of life of patients with myelodysplastic syndromes (MDS).